COVID-19 and Diarylamidines: The Parasitic Connection

As emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants (Omicron) continue to outpace and negate combinatorial vaccines and monoclonal antibody therapies targeting the spike protein (S) receptor binding domain (RBD), the appetite for developing similar COVID-19 treatments h...

Descripción completa

Detalles Bibliográficos
Autor principal: Hulme, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094973/
https://www.ncbi.nlm.nih.gov/pubmed/37047556
http://dx.doi.org/10.3390/ijms24076583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094973/
https://www.ncbi.nlm.nih.gov/pubmed/37047556
http://dx.doi.org/10.3390/ijms24076583

Ejemplares similares